Anteris Technologies Global (AVR) vs XPEL (XPEL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Anteris Technologies Global (AVR) has outperformed XPEL (XPEL) over the past year, gaining 38.4% versus a gain of 30.3%. XPEL is the larger company by market cap ($1.22 billion vs $659.8 million), about 1.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AVR | XPEL |
|---|---|---|
| Share price | $6.77 | $44.43 |
| Market cap | $659.79M | $1.22B |
| 1-day change | +2.11% | -1.09% |
| YTD return | +35.67% | -10.00% |
| 1-year return | +38.45% | +30.32% |
| 5-year return | — | -36.42% |
| P/E ratio (TTM) | — | 22.44 |
| Forward P/E | — | 16.46 |
| EPS (TTM) | $-1.95 | $1.98 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.06 | $55.91 |
| 52-week low | $3.30 | $31.88 |
| Distance from 52-week high | -38.76% | -20.53% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +106.79% | +38.80% |
| Average volume | 935.07K | 204.89K |
| Shares outstanding | 97.46M | 27.57M |
| Employees | 174 | 1,337 |
| Sector | Health Care | Industrials |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Anteris Technologies Global in Health Care and XPEL in Industrials.
About Anteris Technologies Global
AVR stock →Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve.
Health Care · Industrial Specialties · 174 employees
About XPEL
XPEL stock →XPEL, Inc. manufactures, installs, sells, and distributes protective films, coatings and related services.
Industrials · Industrial Specialties · 1,337 employees
AVR vs XPEL FAQ
Which is bigger, Anteris Technologies Global or XPEL?
XPEL (XPEL) is larger, with a market capitalization of $1.22B compared with $659.79M for Anteris Technologies Global (AVR).
Which stock has performed better over the past year, AVR or XPEL?
AVR returned +38.45% over the past 12 months, compared with +30.32% for XPEL (price return, excluding dividends). Past performance does not predict future results.
Are Anteris Technologies Global and XPEL in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.